Fang Tonghua: landing on the standard of traditional Chinese medicine planting, promoting the quality control of the whole process of traditional Chinese medicine production

The development of traditional Chinese medicine industry has been paid more and more attention However, the quality of traditional Chinese medicine has been criticized According to a 2017 annual analysis report on unqualified drug quality data released by yaozhi.com The report involved 4106 batches of substandard drugs Among them, 2618 batches of medicinal materials were unqualified, accounting for 64%; 917 batches of Chinese patent medicines were unqualified, accounting for 22%; 493 batches of chemical drugs were unqualified, accounting for 12% The proportion of the unqualified drugs in the sampling was the highest It can be seen that the quality and safety problems of traditional Chinese medicine industry need to be solved urgently, and the relevant departments and industrial enterprises of the state must pay attention to them At the Symposium of CPPCC members of the National People's Congress of the people's Republic of China on "voice and responsibility" in 2019, long Tonghua, a deputy of the National People's Congress and director of Heilongjiang Treasure Island Pharmaceutical Co., Ltd., said that traditional Chinese medicine is the material basis for the inheritance and development of traditional Chinese medicine, and authentic Chinese medicine is also the representative of traditional high-quality Chinese medicine Genuine medicinal materials have a unique resource origin Only when they are produced in specific fields and regions can they be authentic "At present, there are many Chinese herbal medicines that are not genuine It is suggested that the planting standards of traditional Chinese medicine should also be strengthened, the use of traditional Chinese medicine in the market should be supervised, and the quality and safety problems of traditional Chinese medicine in the use process should be eliminated " In addition, the current Chinese herbal medicine market There are about 17, and currently approved the center for the exchange of medicinal materials With the development of the industry, drug trading should actively embrace the Internet plus new technologies to upgrade the industry, including warehousing, logistics online transactions and offline trading platform, as well as farmers' cooperatives planting platforms, so as to ensure financial support and quality of medicinal materials, thereby ensuring the quality of medicines Quantity Since the 18th National Congress of the Communist Party of China, the State Council has successively issued a series of policies, such as the outline of strategic planning for the development of traditional Chinese medicine (2016-2030), the law of the people's Republic of China on traditional Chinese medicine and the plan for the protection and development of traditional Chinese medicine (2015-2020), marking that the development of traditional Chinese medicine has become a national strategy and that traditional Chinese medicine has entered a new era of comprehensive development And with the proposal of the action plan for poverty alleviation of traditional Chinese medicine industry (2017-2020), new vitality has been injected into the development of traditional Chinese medicine When talking about the development of traditional Chinese medicine industry in our country, Fang Tonghua pointed out that when China first formulated the medical insurance catalogue and the basic medicine catalogue, it put forward the view that both Chinese and Western medicine should be emphasized In the use of traditional Chinese medicine, chemical medicine and biological medicine, the total use of traditional Chinese medicine should be more than 40%, and chemical medicine and biological medicine account for more than 50% Moreover, the state has issued a series of policies to support the development of traditional Chinese medicine, which has greatly encouraged the traditional Chinese medicine industry At present, Chinese medicine enterprises are also increasing industrial capital investment in the development process, especially the development of the whole process of quality control to ensure the quality of drugs, which can basically be included in the provincial and municipal drug quality manufacturing demonstration In addition, Chinese medicine enterprises also actively support the reevaluation of Chinese medicine consistency and injection Of course, this needs a lot of capital support, so Fang Tonghua believes that under the general trend of "drug price reduction", enterprises should be given certain profits on the premise of ensuring product quality "Because technology comes from profit, there is no money to talk about technology Therefore, it is suggested that the National Health Insurance Bureau and the health care Commission should give more policy support to the traditional Chinese medicine industry "